Novacyt S.A. (NVYTF)

Market Cap	42.69M
Revenue (ttm)	24.58M
Net Income (ttm)	-52.28M
Shares Out	n/a
EPS (ttm)	-0.74
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	844
Open	0.5380
Previous Close	0.6410
Day's Range	0.5380 - 0.5380
52-Week Range	0.5374 - 1.2500
Beta	-0.04
RSI	42.82
Earnings Date	Apr 30, 2025

About Novacyt

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 234
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVYTF

Financial Performance

In 2024, Novacyt's revenue was 19.63 million, an increase of 84.82% compared to the previous year's 10.62 million. Losses were -41.76 million, 47.6% more than in 2023.

Financial numbers in GBP